This international consensus statement is the collaborative effort of three medical societies
representing electrophysiology in North America, Europe and Asian-Pacific area: the Heart …

The recommendations listed in this document are, whenever possible, evidence-based.
Unlike other ACC/AHA practice guidelines, there is not a large body of peer-reviewed …

Pacemaker treatment for bradyarrhythmia was first approved for national health insurance
coverage in Japan in 1974, and its use rapidly became widespread thereafter …

4. Delivery of care and ensuring access to care.............. e108 4.1. Recommendations for the
coordination and delivery of care for adults with CHD and arrhythmias …

The online-only Data Supplement is available with this article at http://circ. ahajournals.
org/lookup/suppl/doi: 10.1161/CIR. 0b013e318276ce9b/-/DC1. The online-only …

This revision of the “ACC/AHA/NASPE Guidelines for Implantation of Cardiac Pacemakers
and Antiarrhythmia Devices” updates the previous versions published in 1984, 1991, 1998 …

Background Implantable cardioverter–defibrillators (ICDs) prevent sudden death from
cardiac causes in selected patients but require the use of transvenous lead systems. To …

Background Implantable cardioverter-defibrillators (ICDs) are implanted with the intention to
prolong life in selected patients with inherited arrhythmia syndromes, but ICD implantation is …

This international consensus statement of the European Heart Rhythm Association (EHRA),
Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society is intended to provide …

what is presently known and to outline areas in which additional knowledge is critical to their
care. The focus of this scientific statement will be structural CHD, including coronary artery …